- 25371 Commercentre Dr, Lake Forest, CA 92630
- Patients Results
GTC is built around comprehensive genomic testing that helps physicians move beyond limited answers. With DNA and RNA capabilities across solid tumors, hematologic malignancies, and liquid biopsy applications, GTC is positioned to deliver broader molecular insight that can support diagnosis, prognosis, therapy selection, and biomarker-driven treatment strategies.
The value of molecular profiling is not only in detecting alterations, but in translating them into clinically useful insight. GTC’s testing approach is designed to help physicians identify relevant variants, fusions, expression patterns, and other biomarkers that can support therapeutic planning, patient stratification, and consideration of precision oncology options.
Many clinically relevant findings are missed when testing is limited to DNA alone. GTC emphasizes integrated molecular profiling, including RNA analysis where appropriate, to help uncover fusions, expression changes, transcript-level events, and other biologic signals that may add clinically meaningful context to a patient’s case.
GTC’s physician-facing structure includes resources such as test selection guidance, ordering support, turnaround time information, FAQs, and publications. That positioning reflects a practical focus on helping clinicians not only order the right test, but also navigate the testing process efficiently and interpret the value of the results within real clinical workflows.
GTC supports genomic testing across solid tumors, hematologic malignancies, liquid biopsy applications, and specialized molecular use cases, giving physicians and care teams access to one testing partner across a broad range of clinical scenarios. This helps simplify workflows while supporting continuity across different disease types, specimen settings, and testing needs.
Today’s treatment decisions often depend on more than a single biomarker. GTC’s approach is built around comprehensive molecular profiling that helps physicians evaluate the genomic and transcriptomic complexity of cancer in a way that is more aligned with modern precision oncology and real-world clinical decision-making.
GTC is structured to support physicians not only with advanced testing, but with the practical tools around it. From guidance on what test to order to resources for specimen submission, reporting, and physician support, the testing experience is designed to be more usable, more efficient, and more actionable in practice.
The value of molecular testing is not only in detecting alterations, but in helping physicians decide what comes next. GTC is positioned to support that process by delivering broader molecular insight that can help inform diagnosis, prognosis, therapy selection, biomarker interpretation, and clinical trial consideration.
GTC supports molecular evaluation across solid tumors, hematologic malignancies, liquid biopsy applications, and CNS-focused testing, allowing physicians to work with one testing partner across a broad range of clinical scenarios.
GTC’s broader testing philosophy is aligned with the needs of modern oncology, where treatment planning may depend on mutations, fusions, expression markers, immunotherapy-related biomarkers, and other molecular findings rather than a narrow single-marker approach.
A strong testing partner should help clinicians connect molecular findings to patient management. GTC’s overall test structure and physician resources are clearly aimed at supporting more informed decisions around targeted therapy, immunotherapy, prognosis, and clinical trial matching.
The site architecture itself reflects a physician-oriented workflow, with dedicated pages for What Test to Order, How to Order a Test, and test-specific information. That makes GTC easier to use in practice, especially for teams managing multiple disease types and specimen scenarios.
GTC gives visible importance to turnaround time as part of its physician value proposition, which is critical in oncology settings where delays in molecular results can affect treatment planning, patient counseling, and next-step decisions.
GTC highlights both NGS and AI / machine learning within its physician section, signaling that its model is not only about running advanced assays, but about helping generate interpretable and clinically relevant output from complex molecular data.
With offerings that span DNA, RNA, liquid biopsy, expression-related analysis, and biomarker-focused add-ons, GTC supports a more complete view of tumor biology than approaches centered only on a narrow mutation panel.
Whether the clinical need is standard molecular profiling, fusion-focused analysis, hematologic characterization, or more specialized applications, GTC is positioned as a resource for both common oncology workflows and more diagnostically challenging cases.
What is driving this disease?
Is there a targetable alteration?
Is additional biologic characterization needed?
Could broader profiling change therapy direction or trial eligibility?
GTC’s value proposition is strongest when framed around that reality. Rather than presenting testing as a standalone lab service, the site consistently positions GTC as a clinical resource intended to help physicians obtain more meaningful molecular answers.
For physicians, that matters because today’s oncology decisions increasingly depend on integrated biomarker information.
Comprehensive profiling can influence diagnosis, refine prognostic understanding, identify therapeutic opportunities, and support more individualized treatment strategies.
GTC’s testing portfolio and physician resources suggest a model designed to serve that need across multiple tumor types and practice settings.
Choosing a genomic testing partner is not only about assay breadth. It is also about workflow, responsiveness, and confidence in the output. Physicians and care teams need a lab that makes test selection easier, provides clear ordering guidance, supports specimen submission, and delivers results that are relevant to clinical management. GTC’s physician-focused structure supports that experience through practical educational pages, test guidance, and accessible support pathways.
Explore our genomic tests, identify the right assay for your clinical scenario, and access the physician resources needed to support confident ordering and informed treatment decisions.
